Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Acne Claims For Cosmetics Leave Blemish On UK Advertising Regs

Executive Summary

Advertising Standards Authority issued decisions Oct. 17 on complaints against three cosmetics brands and an online beauty retailer for statements the independent regulator reads as acne-treatment claims, or the “spots” equivalent, calling them medicinal claims for unlicensed products.

You may also be interested in...



Skin 2 Spirit Scrubs Acne Claims On FDA Warning; Moon Valley Psoriasis Claim Persists

FDA’s warning letter to Skin 2 Sprit prompts a quick fix of website claims for the company’s skin care products. FDA advises Moon Valley Natural Products to correct claims that quality its skin care products as misbranded drugs.

Differin Gel Enters Changed Marketplace Since Last OTC Acne Drug Approval

Galderma Labs' adapalene gel is pending launch as first OTC acne ingredient approved through an NDA and first new acne ingredient available OTC in 20 years, but company must play in a digitally-oriented marketplace.

Microplastic Will Gauge EU’s Green Tenacity As Cosmetics Regulatory Revision Looms

Where the European Commission and Member States land in their final deliberations on the proposed microplastic ban could reveal a lot about industry costs deemed acceptable and the level of science considered necessary to regulate cosmetics and other markets in pursuance of Green Deal objectives.

Topics

Related Companies

UsernamePublicRestriction

Register

PS124096

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel